Elgia Therapeutics, Inc.
Pharmaceutical company · San Diego, California, United States
Elgia Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $287,541 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2020.
Elgia Therapeutics at a glance
What does Elgia Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $287,541 in total (2023). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.3 million sold (2020).
Frequently asked questions about Elgia Therapeutics
Where is Elgia Therapeutics headquartered?
Elgia Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Elgia Therapeutics do?
Elgia Therapeutics, Inc. is a pharmaceutical company.
When was Elgia Therapeutics founded?
The earliest incorporation on record for Elgia Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences